SI3156052T1 - Učinki metaboličnega vtisa posebno zasnovane lipidne komponente - Google Patents

Učinki metaboličnega vtisa posebno zasnovane lipidne komponente

Info

Publication number
SI3156052T1
SI3156052T1 SI201232022T SI201232022T SI3156052T1 SI 3156052 T1 SI3156052 T1 SI 3156052T1 SI 201232022 T SI201232022 T SI 201232022T SI 201232022 T SI201232022 T SI 201232022T SI 3156052 T1 SI3156052 T1 SI 3156052T1
Authority
SI
Slovenia
Prior art keywords
specifically designed
lipid component
imprinting effects
metabolic imprinting
designed lipid
Prior art date
Application number
SI201232022T
Other languages
English (en)
Inventor
Der Beek Eline Marleen Van
Marieke Abrahamse-Berkeveld
Annemarie Oosting
Martine Sandra Alles
Original Assignee
N. V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46397603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3156052(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N. V. Nutricia filed Critical N. V. Nutricia
Publication of SI3156052T1 publication Critical patent/SI3156052T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L35/00Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
    • A23L35/10Emulsified foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
SI201232022T 2011-06-16 2012-06-18 Učinki metaboličnega vtisa posebno zasnovane lipidne komponente SI3156052T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2011/050437 WO2012173467A1 (en) 2011-06-16 2011-06-16 Metabolic imprinting effects of specifically designed lipid component
EP16183392.6A EP3156052B1 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component

Publications (1)

Publication Number Publication Date
SI3156052T1 true SI3156052T1 (sl) 2023-03-31

Family

ID=46397603

Family Applications (4)

Application Number Title Priority Date Filing Date
SI201232023T SI3138415T1 (sl) 2011-06-16 2012-06-18 Učinki metaboličnega odtisa posebno zasnovanih lipidnih komponent
SI201232022T SI3156052T1 (sl) 2011-06-16 2012-06-18 Učinki metaboličnega vtisa posebno zasnovane lipidne komponente
SI201230737T SI2720562T1 (sl) 2011-06-16 2012-06-18 Metabolični učinki vtisnjenja posebej oblikovane lipidne komponente
SI201230738T SI2720563T2 (sl) 2011-06-16 2012-06-18 Metabolični učinki vtisnjenja posebej oblikovane lipidne komponente

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI201232023T SI3138415T1 (sl) 2011-06-16 2012-06-18 Učinki metaboličnega odtisa posebno zasnovanih lipidnih komponent

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI201230737T SI2720562T1 (sl) 2011-06-16 2012-06-18 Metabolični učinki vtisnjenja posebej oblikovane lipidne komponente
SI201230738T SI2720563T2 (sl) 2011-06-16 2012-06-18 Metabolični učinki vtisnjenja posebej oblikovane lipidne komponente

Country Status (13)

Country Link
US (3) US20140170260A1 (sl)
EP (4) EP3138415B1 (sl)
CN (4) CN103687500B (sl)
BR (2) BR112013031916B1 (sl)
DK (4) DK3138415T3 (sl)
ES (4) ES2939943T3 (sl)
HR (4) HRP20230159T1 (sl)
MY (2) MY165142A (sl)
PL (4) PL2720563T5 (sl)
PT (4) PT2720562T (sl)
RU (2) RU2586930C2 (sl)
SI (4) SI3138415T1 (sl)
WO (3) WO2012173467A1 (sl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
AR087158A1 (es) 2011-06-20 2014-02-26 Gen Biscuit Masita en capas saludable
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
WO2014058301A1 (en) * 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
US9980506B2 (en) * 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US20140255537A1 (en) * 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Nutritional Compositions Containing an Enriched Lipid Fraction and Uses Thereof
US9661874B2 (en) * 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US20160192678A1 (en) * 2013-07-30 2016-07-07 Benemilk Oy Feed for lactating ruminants
EP2845490A1 (en) * 2013-09-05 2015-03-11 Loders Croklaan B.V. Fat composition for improved body fat distribution
WO2015058115A1 (en) * 2013-10-17 2015-04-23 University Of Georgia Research Foundation, Inc. Structured triacylglycerols and methods for making the same
TR201816481T4 (tr) * 2013-11-01 2018-11-21 Nutricia Nv Yakalama büyümesi sırasında vücut bileşimini geliştirmek için lipit bileşimler.
WO2015067325A1 (en) * 2013-11-11 2015-05-14 N.V. Nutricia Powdered nutritional composition with large lipid globules
US20160015068A1 (en) * 2014-07-16 2016-01-21 Mead Johnson Nutrition Company Nutritional formulas containing oil blends and uses thereof
EP3223825A1 (en) * 2014-11-26 2017-10-04 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
US20180310605A1 (en) 2015-10-15 2018-11-01 N.V. Nutricia Infant formula with milk fat for promoting healthy growth
RU2731641C2 (ru) 2015-10-15 2020-09-07 Н.В. Нютрисиа Детская смесь cо специальной структурой липида для стимулирования здорового роста
CN108882745B (zh) * 2016-03-10 2023-08-18 花臣有限公司 脂质组合物及其用途
WO2018104512A1 (en) * 2016-12-09 2018-06-14 N.V. Nutricia Nutritional composition for improving cell membranes
CN107049240A (zh) * 2017-01-18 2017-08-18 英华达(上海)科技有限公司 身体年龄计算方法及体脂测量系统
RU2761114C2 (ru) * 2017-03-29 2021-12-06 Н.В. Нютрисиа Детская смесь для улучшения пищевого поведения
RU2761065C2 (ru) * 2017-03-29 2021-12-02 Н.В. Нютрисиа Детская смесь для улучшения пищевого поведения
CN109418396A (zh) * 2017-08-22 2019-03-05 中国农业大学 人工脂滴及其应用
WO2019193037A1 (en) * 2018-04-03 2019-10-10 N.V. Nutricia Nutritional composition for use in the prevention of dry skin
US20220386672A1 (en) * 2019-12-05 2022-12-08 N.V. Nutricia Infant formula with special lipid architecture for improving postnatal growth of infants born to overweight and obese mothers
BR112022010232A2 (pt) * 2019-12-05 2022-09-06 Nutricia Nv Método para melhora não terapêutica da trajetória de crescimento ou desenvolvimento corporal pós-natal em um lactente que nasce por cesariana e composição nutricional
EP4346447A1 (en) 2021-05-26 2024-04-10 N.V. Nutricia Infant formula for improving body composition development
EP4346448A1 (en) 2021-05-26 2024-04-10 N.V. Nutricia Infant formula comprising milk fat for reducing the risk of obesity in at risk infants
WO2023203156A1 (en) 2022-04-20 2023-10-26 N.V. Nutricia Infant formula with special lipid architecture for reducing childhood blood pressure
WO2024073465A1 (en) * 2022-09-28 2024-04-04 Cargill, Incorporated Oleosome composition with bio-actives
WO2024073461A1 (en) * 2022-09-28 2024-04-04 Cargill, Incorporated Sunflower oleosome composition
WO2024073463A1 (en) * 2022-09-28 2024-04-04 Cargill, Incorporated Oleosome composition
WO2024073466A1 (en) * 2022-09-28 2024-04-04 Cargill, Incorporated Oleosome composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601860A (en) 1990-11-30 1997-02-11 American Home Products Corporation Corandomized fat compositions for infant formulas
ATE119744T1 (de) * 1991-01-23 1995-04-15 Unilever Nv Muttermilch-fettersatzstoffe.
ES2105712T3 (es) 1993-05-13 1997-10-16 Loders Croklaan Bv Sustitutivos de grasa de leche humana a partir de mezclas interesterificadas de trigliceridos.
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
IL158555A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
WO2006114791A1 (en) * 2005-04-27 2006-11-02 Enzymotec Ltd. Human milk fat substitutes
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
CN103054048B (zh) 2005-12-23 2014-11-19 纽崔西亚公司 用于预防肥胖症的婴儿营养组合物
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
DE102007022694A1 (de) * 2007-05-11 2008-11-13 Humana Milchunion Eg Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme
IL184982A0 (en) * 2007-08-01 2008-01-20 Enzymotec Ltd Edible fat composition for enhancing bone strength
FR2930406B1 (fr) * 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
US8226737B2 (en) 2008-07-03 2012-07-24 3M Innovative Properties Company Fixed abrasive particles and articles made therefrom
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
PL2346355T3 (pl) 2008-09-02 2020-06-01 N.V. Nutricia Kompozycje odżywcze z globulkami lipidowymi o dużej średnicy z powłoką zawierającą polarne lipidy
WO2010068086A1 (en) * 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
WO2011071367A1 (en) 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat

Also Published As

Publication number Publication date
HRP20230159T1 (hr) 2023-03-31
RU2014101211A (ru) 2015-07-27
EP3156052B1 (en) 2022-12-14
PL2720562T3 (pl) 2017-02-28
SI2720563T1 (sl) 2017-03-31
US20160081963A1 (en) 2016-03-24
PT3156052T (pt) 2023-01-27
PL2720562T5 (pl) 2023-04-24
ES2601302T3 (es) 2017-02-14
RU2014101160A (ru) 2015-07-27
HRP20161272T1 (hr) 2017-02-10
ES2601302T5 (es) 2023-06-19
PT2720563T (pt) 2016-11-02
PL3156052T3 (pl) 2023-05-02
ES2601838T5 (es) 2023-06-19
HRP20161272T4 (hr) 2023-03-31
SI2720562T1 (sl) 2017-03-31
MY165142A (en) 2018-02-28
EP2720563B2 (en) 2023-02-22
WO2012173485A1 (en) 2012-12-20
PT2720562T (pt) 2016-11-02
US20140187480A1 (en) 2014-07-03
EP2720563A1 (en) 2014-04-23
DK3138415T3 (da) 2023-01-30
ES2939808T3 (es) 2023-04-27
EP2720562B2 (en) 2023-02-22
CN108041605A (zh) 2018-05-18
CN103763941A (zh) 2014-04-30
BR112013032008A2 (pt) 2016-08-09
US9532966B2 (en) 2017-01-03
PL3138415T3 (pl) 2023-04-03
DK2720562T3 (en) 2016-10-24
HRP20230160T1 (hr) 2023-03-31
MY163520A (en) 2017-09-15
BR112013031916B1 (pt) 2020-09-01
DK2720563T4 (da) 2023-04-03
CN103687500A (zh) 2014-03-26
RU2591716C2 (ru) 2016-07-20
PT3138415T (pt) 2023-01-23
SI3138415T1 (sl) 2023-04-28
CN106262925A (zh) 2017-01-04
EP3156052A1 (en) 2017-04-19
US20140170260A1 (en) 2014-06-19
EP3138415A1 (en) 2017-03-08
ES2939943T3 (es) 2023-04-28
RU2586930C2 (ru) 2016-06-10
BR112013031916A2 (pt) 2016-08-09
DK3156052T3 (da) 2023-01-30
US9649286B2 (en) 2017-05-16
WO2012173486A1 (en) 2012-12-20
PL2720563T5 (pl) 2023-04-24
WO2012173467A1 (en) 2012-12-20
DK2720563T3 (en) 2016-10-17
DK2720562T4 (da) 2023-04-03
EP2720562A1 (en) 2014-04-23
SI2720563T2 (sl) 2023-04-28
EP2720563B1 (en) 2016-08-10
ES2601838T3 (es) 2017-02-16
CN103687500B (zh) 2016-08-31
PL2720563T3 (pl) 2017-02-28
EP2720562B1 (en) 2016-08-10
EP3138415B1 (en) 2022-12-14
HRP20161271T1 (hr) 2016-12-16

Similar Documents

Publication Publication Date Title
PT3156052T (pt) Efeitos de impressão metabólica de componente lipídico especificamente projetado
HK1216310A1 (zh) 脂質合成的雜環調節劑
GB2498228B (en) Provision of an open instance of an application
EP2712362A4 (en) MANUFACTURE OF LACTO-N-TETRAOSE
EP2758987A4 (en) METHOD FOR FORMING A FILM
PL2338484T3 (pl) Efekt imprintingu metabolicznego po podaniu lipidów strukturyzowanych
HK1203827A1 (en) Lipid-based nanoparticles
EP2706992A4 (en) DEFENSIVE EFFECT OF PTEROSTILS
EP2726849A4 (en) CRITICAL SIDE MEASUREMENT
EP2690119A4 (en) SCRIPTURE PREVENTION FILM
EP2724833A4 (en) SUPERFICIAL STRUCTURE OF AN OBJECT
GB2489934B (en) Film
GB201216081D0 (en) An item tag-along
HK1200710A1 (en) Choline composition
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
GB201102171D0 (en) Inspection of holes
GB201109913D0 (en) Lipid metabolism
GB201121152D0 (en) Forming of holes in workplieces
GB201109368D0 (en) Eyeliner effect
GB201109703D0 (en) Magnetic gradiometry
GB201107200D0 (en) Methods of identifying FOXM1 ligands